Kenji Sugio

7PUBLICATIONS
24CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 10, 2026
Narrative review of descending necrotizing mediastinitis, focusing on the etiology, classification-guided surgical management, treatments, and prognosis.

|Sep 01, 2023
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.

Hirotsugu Kenmotsu, Nobuyuki Yamamoto, Toshihiro Misumi

|Jul 17, 2023
Significance of programmed death-ligand 1 expression in resected lung cancer and its relationship with EGFR mutation.

Atsushi Osoegawa, Miyuki Abe, Yohei Takumi

|Jul 23, 2022
Phase II study of S-1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART-1501 study.

Minoru Fukuda, Masafumi Yamaguchi, Takuya Yamazaki

|Nov 02, 2021
Randomized Phase III Study of Gefitinib Versus Cisplatin Plus Vinorelbine for Patients With Resected Stage II-IIIA Non-Small-Cell Lung Cancer With EGFR Mutation (IMPACT).

Hirohito Tada, Tetsuya Mitsudomi, Toshihiro Misumi

|Jan 20, 2021
Resection and postoperative radiation therapy for desmoid fibromatosis of the chest wall in a young woman.

Daiki Noda, Miyuki Abe, Yohei Takumi

Pageof 2

Frequent Collaborators

2 joint publications

Tetsuya Mitsudomi

2 joint publications

Masahiro Tsuboi

2 joint publications

Shunichi Sugawara

2 joint publications

Kazuhiko Nakagawa